![]() |
|
|
|
|||||||||||
|
|||||||||||
|
|||||||||||
|
|||||||||||
|
![]() |
|
||||||||
|
Human LYL1 | |
Rabbit | |
Human, Gibbon (tested or 100% immunogen sequence identity) | |
IgG Polyclonal | |
Biotin. Also available Unconjugated or conjugated with HRP, FITC. | |
Immunoaffinity purified | |
Unmodified |
LYL1 antibody was raised against synthetic peptide from C-Terminus of human LYL1 (P12980). Percent identity by BLAST analysis: Human, Gorilla, Gibbon, Galago (100%). | |
C-Terminus | |
Human LYL1 | |
The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested. |
PBS. | |
Short term, +4°C. Long term, add glycerol to 40-50%, aliquot to avoid freeze/thaw cycles, and store at -20°C. Sensitive to light. | |
For research use only. |
LYL1 Antibody, BHLHa18 Antibody, Protein lyl-1 Antibody
LYL1 represents a basic helix-loop-helix transcription factor. The encoded protein may play roles in blood vessel maturation and hematopoeisis. A translocation between this locus and the T cell receptor beta locus (GeneID 6957) on chromosome 7 has been associated with acute lymphoblastic leukemia.
|